HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S)

Substance profile for UNII 24P2YXD2PW, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
24P2YXD2PW
Preferred term
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S)
Registry number
71138-97-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1313185
PubChem
0
NCIt
C83770
INN ID
0

Open Chemistry Sources#

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (Duloxetine Delayed-Release Capsules) for Oral Use. Initial U.S. Approval: 20042
These highlights do not include all the information needed to use duloxetine safely and effectively. See full prescribing information for duloxetine. Duloxetine Delayed-Release Capsules for Oral Use. Initial U.S. Approval: 20042
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules USP, 0.4 mg Initial U.S. Approval: 19971
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules USP, 0.4 mg Initial U.S. Approval: 19972
These highlights do not include all the information needed to use Cymbalta safely and effectively. See full prescribing information for Cymbalta. Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules for Oral Use. Initial U.S. Approval: 20041
These highlights do not include all the information needed to use Cymbalta safely and effectively. See full prescribing information for Cymbalta. Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules for Oral Use. Initial U.S. Approval: 20041
These highlights do not include all the information needed to use Cymbalta safely and effectively. See full prescribing information for Cymbalta. Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules for Oral Use. Initial U.S. Approval: 20041
These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (duloxetine hydrochloride) capsule, delayed release for oral use Initial U.S. Approval: 20041
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (duloxetine hydrochloride) capsule, delayed release for oral use Initial U.S. Approval: 20041
CYMBALTA (CYMBALTA) CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ]169
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]66
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]46
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]45
PROZAC WEEKLY (FLUOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]37
TAMSULOSIN HYDROCHLORIDE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]10
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]5
MOXATAG (AMOXICILLIN) TABLET, FILM COATED, EXTENDED RELEASE [PRAGMA PHARMACEUTICALS, LLC]3
AMOXICILLIN EXTENDED-RELEASE (AMOXICILLIN) TABLET, FILM COATED, EXTENDED RELEASE [FERA PHARMACEUTICALS, LLC]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [UNIT DOSE SERVICES]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [UNIT DOSE SERVICES]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [UNIT DOSE SERVICES]2
DULOXETINE (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PRASCO LABORATORIES]2
TAMSULOSIN HYDROCHLORIDE CAPSULE [PREFERRED PHARMACEUTICALS, INC.]2
TAMSULOSIN HYDROCHLORIDE CAPSULE [UNIT DOSE SERVICES]2
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ]1
CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ST MARYS MEDICAL PARK PHARMACY]1
TAMSULOSIN HYDROCHLORIDE CAPSULE [PROFICIENT RX LP]1
TAMSULOSIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 24P2YXD2PW page 1 of 1 · 4 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S)24P2YXD2PW71138971CAPSULEORAL34 mg
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S)24P2YXD2PW71138971CAPSULE, DELAYED RELEASEORAL99 mg
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S)24P2YXD2PW71138971CAPSULE, EXTENDED RELEASEORAL43 mg
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S)24P2YXD2PW71138971TABLET, EXTENDED RELEASEORAL26 mg